NEW YORK, Dec. 27, 2010 (GLOBE NEWSWIRE) -- Intellect Neurosciences, Inc. (OTCBB:ILNS), a biopharmaceutical company with an internal preclinical and clinical-stage pipeline and multiple licenses ...

In an industry marked by rapid technological evolution and shifting client expectations, Manish Maakan, Chief Executive ...

Mental health startup Intellect’s ambitious goal is to be available across the Asia-Pacific region, but to ensure localized, culturally competent care in each of the many markets it serves.